BioNTech SE (BNTX) and InstaDeep revealed a long-term joint venture to develop Novel Immunotherapies
BioNTech SE (Nasdaq: BNTX) and InstaDeep Ltd have confirmed a multi-year joint venture aimed at developing new immunotherapies for a variety of cancers and infectious